Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.

NCT00210002 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT00210002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00210002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced.
Lead sponsor
Institut Claudius Regaud
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2003
Completion date
April 30, 2006
Enrollment
55
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neoplasms